CrushSCI.com
Journal Selection & Manuscript Polishing Services
Biomarker Research journal cover Medicine
Back to journal directory

Review Cycle Records

Biomarker Research

Springer SCIE OA
2026 Emerging Zone 12025 CAS Zone 22025 JCR Q1
102.1Average days
96Median days
40Fastest days
164Longest days
1662025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

97 days

Clinical implications of serum GDF15 propeptide as a biomarker for bone metastasis across common solid tumors: a real-world multi-institutional study

AuthorsGaku Yamamichi; Taigo Kato; Atsuki Matsukawa; Nanae Masunaga; Haruhiko Hirata; Jun Okuno; Norihiko Kawamura; Kei Kunimasa; Ikumi Seto; Takanori Kin; Kentaro Masuhiro; Shinya Sato; Shohei Myoba; Shinobu Ikeda; Takeshi Ujike; Yu Ishizuya; Takuji Hayashi; Yoshiyuki Yamamoto; Koji Hatano; Atsunari Kawashima; Yohei Miyagi; Motohide Uemura; Kazumi Nishino; Takahiro Nakayama; Masashi Nakayama; Yoshito Takeda; Kenzo Shimazu; Norio Nonomura

Affiliations1. Department of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan; 2. Department of Breast and Endocrine Surgery, The University of Osaka Graduate School of Medicine, Suita, Japan; 3. Department of Respiratory Medicine and Clinical Immunology, The University of Osaka Graduate School of Medicine, Suita, Japan; 4. Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan; 5. Department of Urology, Osaka International Cancer Institute, Osaka, Japan; 6. Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan; 7. Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan; 8. Bioscience Division, Research and Development Department, Tosoh Corporation, Ayase, Japan; 9. Medical Center for Translational Research, Department of Medical Innovation, The University of Osaka Hospital, Suita, Japan; 10. Department of Urology, Osaka Rosai Hospital, Sakai, Japan; 11. Department of Urology, Iwase General Hospital, Sukagawa, Fukushima, Japan; 12. Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan

Source PDF DOI Publisher page
164 days

FECH, a novel metabolic target influencing CAR T-cell phenotype and function

AuthorsMarsha Pellegrino; Simone Vespa; Illari Salvatori; Giang Dang Mac; Cristiana Valle; Valerio Secli; Sara Cairoli; Bianca Maria Goffredo; Matteo Caforio; Valentina Folgiero; Lokossou William Sanvi; Elisabetta Vulpis; Elena Ciampini; Marco Scarsella; Ezio Giorda; Ferdinando Chiaradonna; Manuela Giansanti; Francesca Nazio; Alberto Ferri; Francesco Cecconi; Silvia Campello; Enrico Velardi; Ignazio Caruana; Emmanuel de Billy

Affiliations1. Department of Onco-Hematology, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; 2. Laboratory for Cell and Gene Therapy, Department of Paediatrics, Stem Cell Transplantation and Cell Therapy, University Hospital Würzburg, Würzburg, Germany; 3. Santa Lucia Foundation, IRCCS, Rome, Italy; 4. National Research Council (CNR), Institute of Translational Pharmacology (IFT), Rome, Italy; 5. Bambino Gesù Children’s Hospital, Division of Metabolic Diseases and Drug Biology, IRCCS, Rome, Italy; 6. Department of Experimental Medicine (DIMES), University of Genova, Genova, Italy; 7. Department of Biology, University of Rome Tor Vergata, Rome, Italy; 8. Department of Basic Biotechnological Sciences, Intensive Care and Perioperative Clinics Research, Catholic University of the Sacred Heart, Rome, Italy; 9. Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; 10. Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy; 11. Innate Lymphoid Cells Unit, Immunology Research Area, Bambino Gesù Children’s Hospital IRCCS, Rome, Italy; 12. Catholic University of the Sacred Heart, Rome, Italy; 13. Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; 14. Department of Pediatrics - Hematology, Oncology, Stem Cell Transplantation and Cell Therapy, University Hospital Würzburg, Würzburg, Germany

Source PDF DOI Publisher page
160 days

Biomarker implications of gene editing in hematologic diseases: latest updates from ASH 2025

AuthorsZezhou Zang; Wei Zheng; Ruirong Xu; Siyuan Cui

Affiliations1. Shandong University of Traditional Chinese Medicine, Jinan, China; 2. Department of Hematology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China; 3. Institute of Hematology, Shandong University of Traditional Chinese Medicine, Jinan, China

Source PDF DOI Publisher page
141 days

EGF as a non-invasive biomarker of endometriosis: a case control study

AuthorsEmma R. Rashes Gertel; Cassandra C. Daisy; Katherine Kaplan; Steven J. Staffa; David Zurakowski; Allison F. Vitonis; Kathryn L. Terry; Amy L. Shafrir; Simon T. Dillon; Stacey A. Missmer; Michael S. Rogers; Towia A. Libermann; Marsha A. Moses

Affiliations1. Vascular Biology Program, Boston Children’s Hospital, Boston, USA; 2. Department of Surgery, Boston Children’s Hospital, Boston, USA; 3. Department of Anesthesiology, Boston Children’s Hospital, Boston, USA; 4. Harvard Medical School, Boston, USA; 5. Boston Center for Endometriosis, Boston Children’s Hospital and Brigham and Women’s Hospital, Boston, USA; 6. Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women’s Hospital, Boston, USA; 7. Department of Surgery, Harvard Medical School, Boston, USA; 8. Division of Adolescent and Young Adult Medicine, Department of Medicine, Boston Children’s Hospital, Boston, USA; 9. Department of Nutrition and Public Health, School of Nursing and Health Sciences, Merrimack College, North Andover, USA; 10. Genomics, Proteomics, Bioinformatics and Systems Biology Center, Beth Israel Deaconess Medical Center, Boston, USA; 11. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA; 12. Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, USA; 13. Vascular Biology Program and Department of Surgery, Boston Children’s Hospital Boston and Harvard Medical School, Boston, USA

Source PDF DOI Publisher page
155 days

Identifying the angiogenic receptor expression in mantle cell lymphoma patients and murine models

AuthorsSatishkumar Singh; Yuanfeng Wang; Anuvrat Sircar; Udita Jindal; Noura Srour; Alessandro La Ferlita; Rosario Distefano; Astha Soni; Deepak Kumar; German J. Peralta-Camacho; Serena Li Zhao; Hedieh Jafari; Jacob C. Holter; Joseph W. Tinapple; Joseph M. Barlage; Rathan Kumar; Maxine Berger; Khaliqur Rahman; Reza Nezati; Uttam Kumar Nath; Nazia Chaudhary; Parvathi Ranganathan; Natarajan Muthusamy; Virginia Amador; Pui Kai Li; Samir Parekh; Jihye Paik; Robert Baiocchi; Jonathan W. Song; Lapo Alinari; Blake R. Peterson; Narendranath Epperla; Neeraj Jain; Lalit Sehgal

Affiliations1. Division of Hematology, College of Medicine, The Ohio State University, Columbus, USA; 2. The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, USA; 3. AstraZeneca Pharmaceuticals, Hematology R&D, Waltham, USA; 4. Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow, India; 5. Academy of Scientific and Innovative Research, Ghaziabad, India; 6. Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, USA; 7. Department of Biomedical Engineering, The Ohio State University, Columbus, USA; 8. Department of Biomedical Education and Anatomy, The Ohio State University, Columbus, USA; 9. Department of Hematology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India; 10. Department of Pathology, Fox Chase Cancer Center, Philadelphia, USA; 11. Department of Medical Oncology & Hematology, All India Institute of Medical Sciences, Rishikesh, India; 12. Cell and Tumor Biology, Advanced Center for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Center, Kharghar, Navi Mumbai, India; 13. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; 14. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; 15. Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; 16. Precision Immunology Institute, Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, USA; 17. Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, USA; 18. Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, USA; 19. Department of Mechanical and Aerospace Engineering, The Ohio State University, Columbus, USA; 20. Division of Hematology, Department of Internal Medicine, University of Utah, Salt Lake City, USA

Source PDF DOI Publisher page
95 days

Interleukin-10 enhances IgG galactosylation and sialylation

AuthorsHanna B. Lunding; Anna M. Wasynczuk; Yannic C. Bartsch; Jana Sophia Buhre; Jan Nouta; Alexei Leliavski; Selina Lehrian; Anna Emilia Becker; Kristina Manzhula; Philipp Köcher; Janina Mehlfeld; Johann Rahmöller; Manfred Wuhrer; Marc Ehlers

Affiliations1. Laboratory of Immunology, Institute of Nutritional Medicine, University of Luebeck and University Hospital Schleswig-Holstein, Luebeck, Germany; 2. Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands; 3. Laboratory of Anti-Viral Antibody-Omics, TWINCORE – Institute for Experimental and Clinical Infection Research, Helmholtz Center for Infection Research (HZI) and Medical School Hannover (MHH), Hannover, Germany; 4. Department of Anesthesiology and Intensive Care, University of Luebeck and University Hospital Schleswig-Holstein, Luebeck, Germany; 5. Department of Anesthesiology, Haraldsplass Diakonale Sykehus, Bergen, Norway; 6. German Center for Lung Research (DZL), University of Luebeck, Luebeck, Germany

Source PDF DOI Publisher page
131 days

Disrupted glutathione homeostasis in the pathogenesis of TTR-V30M amyloidosis

AuthorsAnushree Bachhar; Gabriella Johannson; Melisnur Sahin; Sanduni Jayaweera; Malin Olsson; Intissar Anan; Anders Olofsson

Affiliations1. Department of Clinical Microbiology, Umeå University, Umeå, Sweden; 2. Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Source PDF DOI Publisher page
91 days

CD163 + macrophages coordinate erythroblastic Island formation and iron metabolism to enable glucocorticoid-induced erythropoiesis

AuthorsMengjia Li; Yaomei Wang; Hong Huang; Hao Sun; Mengya Gao; Mingxia Sun; Xudong Li; Zexing Liu; Donghao Liu; Meimei Yan; Zhenghua Huang; Zhen Zhang; Yuhan Hu; Bozheng Wang; Yiwei Zhou; Siyue Li; Yu An; Miao Liu; Yupeng Liu; Fengcai Gao; Fangfang Ge; Wenjuan Fan; Hao Wang; Xing Li; Fang Wang; Guomei Fu; Shiyu Zuo; Binglei Zhang; Jinxin Miao; Chong Wang; Yongping Song; Xiuli An; Weijie Cao; Linping Xu; Wei Li; Zhilei Bian

Affiliations1. Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 2. Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China; 3. Department of Radiotherapy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 4. School of Public Health, Zhengzhou University, Zhengzhou, China; 5. Department of Research and Foreign Affairs, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China; 6. School of Life Science, Zhengzhou University, Zhengzhou, China; 7. Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China; 8. Department of Abdominal and Pelvic Tumor Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 9. Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, China; 10. Laboratory of Membrane Biology, New York Blood Center, New York, USA; 11. Institute of Infection and Immunity, Henan Academy of Innovations in Medical Science, Zhengzhou, China

Source PDF DOI Publisher page
40 days

Cell death crosstalk in NET-Driven inflammation: mechanisms, disease contexts, and therapeutic perspectives

AuthorsLizhou Song; Tian Zhou; Yue Shu; Jibo Zhao; Yan Liao; Chenglong Zhu; Haoling Zhang; Wangzheqi Zhang; Zui Zou

Affiliations1. Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China; 2. School of Anesthesiology, Naval Medical University, Shanghai, China; 3. School of Anesthesiology, Hebei North University, Hebei, China; 4. Department of Anesthesiology, the First Affiliated Hospital of Hebei North University, Zhangjiakou, China; 5. Department of Biomedical Sciences, Cancer Research and Specialist Centre, Universiti Sains Malaysia, Penang, Malaysia

Source PDF DOI Publisher page
123 days

INHBA–S100A16 dysregulation enables a non-invasive molecular stratification platform for rapid detection of oral squamous cell carcinoma: results from a large diagnostic case-control study

AuthorsMuy-Teck Teh; Ranjitkumar Patil; Satyajit Ashok Tekade; Deepika Mishra; Akhilanand Chaurasia; Ahmad Waseem

Affiliations1. Centre for Oral Immunobiology & Regenerative Medicine, Institute of Dentistry, Barts & The London School of Medicine and Dentistry, Queen Mary University of London, London, UK; 2. Department of Oral Medicine & Radiology, King George’s Medical University, Lucknow, India; 3. Department of Oral & Maxillofacial Pathology, Modern Dental College & Research Centre, Indore, India; 4. Department of Oral Pathology & Microbiology, Centre of Dental Education & Research, All India Institute of Medical Sciences, New Delhi, India

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.